Table 3 Baseline neuropsychological characteristics and post-treatment changes according to the A-3081T genotype of SLC6A2
|  | AA (n = 13) | AT (n = 28) | TT (n = 12) |  | AA (n = 13) | AT + TT (n = 40) | Difference (95% CI) |  |
|---|---|---|---|---|---|---|---|---|
| Â | Mean (SD) | Mean (SD) | Mean (SD) | p-value | Mean (SD) | Mean (SD) | Difference (95% CI) | p-value |
Baseline | ||||||||
Omission errors | 64.69 (7.00) | 61.75 (3.63) | 68.42 (7.14) | 0.677 | 64.69 (7.00) | 63.75 (3.31) | 0.94 (-13.16-15.05) | 0.894 |
Commission errors | 51.54 (3.79) | 54.64 (3.39) | 69.67 (10.02) | 0.088 | 51.54 (3.79) | 59.15 (3.91) | −7.61 (-22.10-6.88) | 0.297 |
Response time | 54.15 (4.19) | 58.36 (2.47) | 57.25 (6.08) | 0.727 | 54.15 (4.19) | 58.02 (2.47) | −3.87 (-13.81-6.06) | 0.438 |
Response time variability | 69.15 (7.74) | 64.46 (2.18 | 75.42 (4.32) | 0.727 | 69.15 (7.74) | 64.75 (1.97) | 4.40 (-6.74-15.55) | 0.431 |
Post-treatment change (%)a | ||||||||
Omission errors | −14.12 (5.7) | −8.75 (3.78) | −11.67 (6.27) | 0.728 | −14.12 (5.7) | −9.63 (3.21) | −4.49 (-17.54-8.55) | 0.493 |
Commission errors | 10.05 (8.04) | −7.12 (2.92) | −14.79 (4.52) | 0.007 | 10.05 (8.04) | −9.42 (2.49) | 19.48 (6.88-32.09) | 0.003 |
Response time | −15.82 (6.81) | 1.26 (6.00) | −7.38 (10.27) | 0.259 | −15.82 (6.81) | −1.33 (5.18) | −14.48 (-34.35-5.39) | 0.150 |
Response time variability | −13.12 (5.39) | −2.45 (2.33) | −6.48 (4.42) | 0.150 | −13.12 (5.39) | −3.66 (2.09) | −11.52 (-24.79-1.74) | 0.087 |